See also this year's filing and all EDGAR filings for this company.
PDF Report 0001322505_2020_Albireo_Pharma_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001322505, Albireo Pharma INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 141,799,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 17,260,000 |
| 2 | PropertyPlantAndEquipmentNet | 597,000 |
| 3 | remainder_Assets | 5,413,000 |
| 4 | LiabilitiesCurrent | 18,924,000 |
| 5 | LiabilitiesNoncurrent | 4,270,000 |
| 6 | remainder_Liabilities | 48,714,000 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 22,726,954 |
| 9 | ResearchAndDevelopmentExpense | 59,657,023 |
| 10 | remainder_Expenses | 1,927,987 |
| 11 | remainder_Revenues | 11,268,286 |
| 12 | remainder_NetIncome | -4,324,755 |
| 13 | remainder_ComprehensiveNetIncome | 2,610,931 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 165,069,000 |
| 1 | Liabilities | 71,908,000 |
| 2 | Expenses | 84,311,964 |
| 3 | Revenues | 11,268,286 |
| 4 | StockholdersEquity | 93,161,000 |
| 5 | NetIncome | -77,368,433 |
| 6 | ComprehensiveNetIncome | -76,062,968 |
| 7 | BaseVar | 169,746,468 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 1.07 |
| 9 | EconomicCapitalRatio | 2.36 |
Edgar->Model Mapping
Feature Distribution
Change over Time
